Affiliation:
1. Blokhin National Medical Research Center of Oncology;
Sechenov First Moscow State Medical University (Sechenov University)
2. Blokhin National Medical Research Center of Oncology
Abstract
Bone sarcomas account for 7% of malignant tumors in children, and osteosarcomas make up 35–50% of them. Many patients are diagnosed at spread stages of the disease, which dictates the need to search for new approaches to treatment. At the same time, the optimal therapeutic strategy is unknown, the results of treatment of such children remain unsatisfactory. Part I of this article describes currently used treatment regimens. Part II presents achievements in the field of personalized therapy. Thus, changes in treatment approaches illustrate the vector of development of the treatment principles of such complex diseases, being fatal for most patients a few years ago.
Publisher
The National Academy of Pediatric Science and Innovation
Subject
Pediatrics, Perinatology, and Child Health
Reference32 articles.
1. Isakoff M.S., Bielack S.S., Meltzer P., Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. J Сlin Oncol 2015; 33(27): 3029–3035. DOI: 10.1200/JCO.2014.59.4895.
2. Punanov Yu.A., Andreeva T.V., Gafton G.I., Gudz Y.V., Safonova S.A., Nabokov V.V., Novik V.I. The Results of Combined Therapy in Children and Adolescents with Osteosarcoma. Onkopediatriya (Onkopediatria) 2014; 1(2): 49–53. (in Russ)
3. Doyle L.A. Sarcoma classification: An update based on the 2013 World health organization classification of tumors of soft tissue and bone. Cancer 2014; 120(12): 1763–1774. DOI: 10.1002/cncr.28657
4. Fletcher C.D.M., Bridge J.A., Hogendoorn J.A., Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone. WHO, 2013; 427.
5. Ritter J., Bielack S.S. Osteosarcoma. Ann Oncol 2010; 21: 320–325. DOI: 10.1093/annonc/mdq276.